By Dr. Leandro Pucci, DCN, CNS, CKNS, LDN
A nutrigenomic test can tell you how your body is likely to handle specific nutrients: how fast you clear caffeine, how efficiently you make omega-3 fats, whether you need more choline than most people, and where your iron or vitamin D status may drift. It cannot tell you which diet will make you lose the most weight, and it does not diagnose disease. Used well, it narrows the questions your bloodwork needs to answer. Used alone, it mostly generates supplement lists.
I use the 3X4 Genetics Blueprint in my Comprehensive Metabolic Optimization Program. Patients often arrive expecting the report to be a verdict. In practice, it works more like a map of where to look first. This article explains what the test measures, which findings have solid human evidence, where the evidence runs out, and how I turn a report into a plan. For the deeper metabolic mechanisms (APOE, TCF7L2, methylation and the liver), see my earlier article, Precision Metabolic Optimization.
Your DNA differs from everyone else's at millions of single-letter positions called single nucleotide polymorphisms (SNPs). A small fraction of them change how an enzyme, transporter, or receptor works. Nutrigenomic panels test a curated set of these SNPs in genes involved in nutrient handling, inflammation, detoxification, hormones, and energy metabolism.
The 3X4 Blueprint uses a cheek swab and reports on more than 134 genes grouped into 36 pathways across six areas: cellular health, body systems, cardiovascular health, energy, activity, and nutrients (2). Each pathway receives an impact rating from low to very high, based on how many relevant variants you carry and how strongly each is thought to matter. The report opens with a summary plan for your three highest-impact pathways, each with suggested diet, lifestyle, and supplement steps.
Two features of the format are worth understanding before you read your own report:
An international group of nutrigenetics researchers proposed a framework for this in 2017 (1). Paraphrased into three practical questions:
A finding that passes all three can change what I recommend. A finding that passes the first one only is worth knowing, but it is a hypothesis to check with labs, not an instruction.
Several genetic findings in the 3X4 Blueprint have meaningful human research behind them and can help guide targeted testing and nutrition strategies.
The CYP1A2 gene influences how quickly your body metabolizes caffeine. Research involving 2,014 heart attack cases and matched controls found that slow caffeine metabolizers who drank two to three cups of coffee daily had a 36% higher risk of heart attack, while those drinking four or more cups had a 64% higher risk. No increased risk was observed among fast metabolizers in the study.
What this means for your nutrition: If you are a slow caffeine metabolizer, limiting coffee to approximately one cup per day and drinking it before noon may be worth considering. Fast metabolizers may generally tolerate coffee without the same concerns.
___
The FADS1 and FADS2 genes influence how efficiently your body converts plant-based omega-3 fatty acids, known as ALA, into the more readily usable forms EPA and DHA. These nutrients are important for overall health, and common genetic variations can affect how efficiently this conversion occurs.
What this means for your nutrition: If you are a low converter, relying solely on plant-based sources such as flaxseed, chia seeds, and walnuts may not provide sufficient EPA and DHA. Consider incorporating direct sources of EPA and DHA, such as fatty fish or algae-based options. An omega-3 index test can also help assess your levels.
___
The GC and CYP2R1 genes are involved in vitamin D transport and metabolism. A large genome-wide study found that individuals with the highest genetic risk scores had approximately 2.5 times the odds of vitamin D insufficiency compared with those at lower genetic risk.
What this means for your nutrition: Genetic risk may make it especially important to monitor vitamin D levels. Testing 25(OH)D, the standard measure of vitamin D status, can help determine whether supplementation is needed. Retesting can help evaluate whether levels have improved, particularly for individuals with higher-risk genetic profiles.
___
The FUT2 gene influences certain aspects of gut function and nutrient absorption. Common genetic variations in this gene have been associated with differences in blood vitamin B12 levels, likely related in part to gut absorption.
What this means for your nutrition: Rather than assuming your B12 status based on genetic results alone, consider checking vitamin B12 levels. Testing methylmalonic acid (MMA) alongside B12 can provide additional insight into whether your body has adequate B12 available for normal cellular function.
___
The MTHFR gene plays a role in processing folate, a B vitamin essential for several important processes in the body. A particular MTHFR variant, known as 677TT, has been associated with higher homocysteine levels.
Research found that among individuals with two copies of this variant, riboflavin (vitamin B2) supplementation lowered homocysteine levels by 22%, with reductions reaching 40% among those with low riboflavin status. The same effect was not observed in individuals with other genotypes.
What this means for your nutrition: Monitoring homocysteine levels may be helpful in understanding how your body is processing certain B vitamins. Prioritizing foods rich in riboflavin and folate is a good starting point. Supplements may be considered when testing indicates a need, particularly if homocysteine levels remain elevated.
___
The PEMT gene is involved in the body's production of phosphatidylcholine, an important compound that supports liver function and cell structure. Research examining adults on a low-choline diet found that 78% of individuals carrying one PEMT variant developed signs of fatty liver or muscle damage. The study was relatively small, involving 57 people.
What this means for your nutrition: Paying attention to daily choline intake may be especially important for individuals with certain PEMT variants. Foods such as eggs, fish, and liver are good sources of choline. This may be particularly relevant for individuals following plant-heavy diets or those who consume limited amounts of animal-based foods.
___
The HFE gene helps regulate iron absorption in the body. One particular variant, C282Y, is associated with hereditary hemochromatosis, a condition that can cause the body to absorb and store excessive amounts of iron.
Long-term research found that over a 12-year period, 28% of men carrying two copies of this variant developed iron-overload disease, compared with approximately 1% of women.
What this means for your nutrition: If you carry two copies of the C282Y variant, monitoring iron levels is important. Blood tests measuring ferritin and transferrin saturation can help identify potential iron overload. If levels are elevated, consult a healthcare professional. Avoid taking additional iron supplements unless testing indicates they are needed and a healthcare professional recommends them.
___
The HLA-DQ2 and HLA-DQ8 genes are closely associated with celiac disease, an autoimmune condition triggered by gluten. Not carrying these genetic markers makes celiac disease very unlikely. However, carrying one or both does not mean you have celiac disease, since these variants are also relatively common in the general population.
What this means for your nutrition: If genetic testing identifies HLA-DQ2 or HLA-DQ8 and you experience symptoms associated with gluten consumption, additional testing may be appropriate. Antibody testing should be completed before eliminating gluten from your diet, because following a gluten-free diet beforehand can make test results unreliable.
The most common question I get is some version of "Which diet is right for my genes?" For weight loss, the best evidence says genes don't answer it.
There is also a behavioral finding worth knowing. A meta-analysis of 18 studies found that telling people their genetic risk for common diseases did not, on average, change their diet, exercise, or smoking (13). In the large Food4Me trial, personalized nutrition advice improved diet quality, but adding genetic results on top of diet and lab data did not improve it further (14). Specific, actionable gene findings may be different: in one trial, people told they carried a salt-sensitive ACE variant cut sodium more than people given standard advice.
The practical lesson: a gene result helps when it changes a specific, concrete recommendation, and much less when it is offered as general motivation.
The report is one of three data layers I work from: your history and symptoms, your bloodwork, and your genes. The genes go last in that order, because they are the only layer that never changes. Here is the sequence in my program.
For patients working on blood sugar or a lipid panel that changed on low-carb, my articles on insulin resistance testing and on high LDL on keto describe the labs I pair with the genetic results.
Privacy and Genetic Information
In the United States, the Genetic Information Nondiscrimination Act (GINA) bars health insurers from using genetic information for coverage or pricing decisions, and bars most employers from using it in hiring or firing. GINA does not cover life, disability, or long-term care insurance, and its employment protections do not apply to employers with fewer than 15 employees (16). If you are planning to apply for those policies, it is reasonable to consider timing. Ask any testing company how your sample and data are stored and whether they are shared.
Want to see what your genes add to your labs? The 3X4 Genetics Blueprint is part of my Comprehensive Metabolic Optimization Program, alongside a metabolic and cardiovascular panel and an organic acids test.
Book a discovery call or read more about how I work with patients.
This article is for educational purposes and is not medical advice. Nutrigenomic tests are not diagnostic tests.
References
